Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Aquestive Therapeutics, Inc. (AQST) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Other Events  Interactive Data
Docs: "Aquestive Therapeutics Provides Business Update"
08/11/2023 8-K Investor presentation
Docs: "of the Private Securities Litigation Reform Act of 1995. Words"
08/07/2023 8-K Investor presentation, Quarterly results
Docs: "Exhibit 99.1 Aquestive Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update"
08/02/2023 8-K Quarterly results
07/27/2023 8-K Regulation FD Disclosure  Interactive Data
Docs: "Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data for Anaphylm™ Sublingual Film"
06/29/2023 8-K Investor presentation
Docs: "Aquestive Therapeutics Corporate Presentation",
"Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment"
05/31/2023 8-K Investor presentation
Docs: "Aquestive Therapeutics Reports Positive Results from Latest Clinical Studies Evaluating Pharmacokinetic and Pharmacodynamic Performance of Anaphylm"
05/02/2023 8-K Quarterly results
04/13/2023 8-K Quarterly results
03/07/2023 8-K Investor presentation
03/07/2023 8-K Investor presentation, Quarterly results
Docs: "Aquestive Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Business Update on Key 2023 Objectives",
"2022 14.7 17.7 18.6 27.3 0 5 10 15 20 25 30"
03/06/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
02/07/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "AMENDED AND RESTATED BYLAWS OF AQUESTIVE THERAPEUTICS, INC."
01/03/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
12/22/2022 8-K Quarterly results
12/20/2022 8-K Quarterly results
11/07/2022 8-K Other Events  Interactive Data
11/02/2022 8-K Quarterly results
11/01/2022 8-K Quarterly results
10/27/2022 8-K Quarterly results
10/24/2022 8-K Quarterly results
10/11/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Aquestive Therapeutics Receives Positive FDA Written Response for AQST-109 Epinephrine Sublingual Film"
09/28/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Aquestive Therapeutics Enters License and Supply Agreement with Pharmanovia for"
09/27/2022 8-K Investor presentation
Docs: "September 2022 EPIPHAST II Trial Results Supplemental Materials 1",
"Aquestive Therapeutics Announces Positive EPIPHAST II Trial Data for AQST-109 When Compared to"
09/07/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Opinion of Dechert LLP"
08/31/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ET on August 31, 2022 WARREN, N.J., Aug. 31, 2022"
08/24/2022 8-K Other Events  Interactive Data
08/10/2022 8-K Quarterly results
08/03/2022 8-K Quarterly results
08/02/2022 8-K Quarterly results
Docs: "Aquestive Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update"
07/19/2022 8-K Quarterly results
07/15/2022 8-K Quarterly results
07/11/2022 8-K Quarterly results
06/24/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy